Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain
This study has been completed.
Study NCT00082316 Information provided by NeurogesX
First Received: May 5, 2004 Last Updated: January 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Herpes Zoster
Neuralgia
Pain
HIV Infections
Peripheral Nervous System Diseases
Diabetic Neuropathies
Diabetes Mellitus
Polyneuropathies
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Communicable Diseases
Infection
Nervous System Diseases
More general conditions related to this trial
Diabetes Complications
DNA Virus Infections
Endocrine System Diseases
Glucose Metabolism Disorders
Herpesviridae Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Metabolic Diseases
Neurologic Manifestations
Neuromuscular Diseases
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Signs and Symptoms
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Capsaicin Dermal Patch
Additional drug interventions recognized in this trial
Anesthetics
Anesthetics, Local
Capsaicin
More general drug interventions related to this trial
Antipruritics
Central Nervous System Agents
Central Nervous System Depressants
Dermatologic Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
NeurogesX
Back to top of Main Content
